Skip to Main Content

Paper Details

Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
Am J Obstet Gynecol
13
2022
breast cancer, desogestrel, drospirenone, estradiol, estrogen, ethinyl, ethynodiol diacetate, human, human epidermal growth factor receptor 2, invasive breast cancer, levonorgestrel, norethindrone, norethindrone acetate, norgestimate, norgestrel, progesterone, progestin, progestins, tumor, tumor subtype, women
Author NameAffiliation
Bernard RosnerBrigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, Harvard University
Rudolf KaaksGerman Cancer Research Center (DKFZ)
Ren??e T FortnerGerman Cancer Research Center (DKFZ)
  • 1 - 3

Datasets

Release 1.2